Komipharm International Co., Ltd. (KOSDAQ:041960)

Komipharm International Revenue

Komipharm International had revenue of 16.70B KRW in the quarter ending June 30, 2026, with 22.11% growth. This brings the company's total for the last twelve months to 53.02B, down -3.27% year-over-year. In the year 2025, Komipharm International had annual revenue of 52.47B, down -10.74%. That makes Komipharm International the 29,572nd largest company in the world by revenue and 1,825th in South Korea.

• Revenue (ttm): 53.02B
• Revenue Growth: -3.27%
• P/S Ratio: 11.86
• Revenue / Employee: 329.30M
• Employees: 161
• Market Cap: 628.95B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 29.63B 56.5%
• Other Asia 3.96B 7.5%
• Pakistan 3.90B 7.4%
• Bangladesh 3.86B 7.3%
• Middle East 3.84B 7.3%
• Africa 3.40B 6.5%
• Thailand 2.36B 4.5%
• South America, Europe 1.52B 2.9%

Fiscal year ended Dec 31, 2025 See the full Komipharm International breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	52.47B	-6.31B	-10.74%
Dec 31, 2024	58.78B	16.13B	37.83%
Dec 31, 2023	42.65B	2.85B	7.15%
Dec 31, 2022	39.80B	3.95B	11.03%
Dec 31, 2021	35.85B	-1.31B	-3.53%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error